This is the list of the largest public listed companies in the Drug Manufacturers—Specialty & Generic industry from Switzerland by market capitalization with links to their reference stock.
| Rank | Company | Market Cap (USD) | Country | Sector | Industry |
|---|---|---|---|---|---|
| 1 | Vifor Pharma AG |
$11.57 B
(Dec. 1, 2022) |
Switzerland | Swiss Healthcare | Swiss Drug Manufacturers—Specialty & Generic |
| 2 | Siegfried Holding AG | $4.12 B | Switzerland | Swiss Healthcare | Swiss Drug Manufacturers—Specialty & Generic |
| 3 | PolyPeptide Group AG |
$876.3 M
(July 1, 2025) |
Switzerland | Swiss Healthcare | Swiss Drug Manufacturers—Specialty & Generic |
| 4 | SES Solar, Inc. | Switzerland | Swiss Healthcare | Swiss Drug Manufacturers—Specialty & Generic |
Company Profile:
Vifor Pharma AG
Market Cap (USD):
$11.57 B
(Dec. 1, 2022)
Country:
Switzerland
Sector:
Swiss Healthcare
Industry:
Swiss Drug Manufacturers—Specialty & Generic
Company Profile:
Siegfried Holding AG
Market Cap (USD):
$4.12 B
Country:
Switzerland
Sector:
Swiss Healthcare
Industry:
Swiss Drug Manufacturers—Specialty & Generic
Company Profile:
PolyPeptide Group AG
Market Cap (USD):
$876.3 M
(July 1, 2025)
Country:
Switzerland
Sector:
Swiss Healthcare
Industry:
Swiss Drug Manufacturers—Specialty & Generic
Company Profile:
SES Solar, Inc.
Country:
Switzerland
Sector:
Swiss Healthcare
Industry:
Swiss Drug Manufacturers—Specialty & Generic